How much is Cidara Therapeutics worth in 2026?

Cidara Therapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Cidara Therapeutics raised?

Cidara Therapeutics has raised N/A in total funding across 2 funding rounds.

Cidara Therapeutics

Drug Discovery

Cidara Therapeutics valuation and funding history | Last updated: November 25, 2024 | 2 funding rounds

Current Valuation

N/A

As of November 25, 2024

Total Funding Raised

N/A

Across 2 rounds

Last Round

PIPE

$105.0M

Last Funding

Nov 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 25, 2024	PIPE	$105.0M	N/A	-
April 24, 2024	PIPE	$240.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Cidara Therapeutics is currently valued at N/A as of November 25, 2024.

Track Cidara Therapeutics Valuation Updates

Get notified when Cidara Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Cidara Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Cidara Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Cidara Therapeutics Worth in 2026?

Cidara Therapeutics is a leading private company in the Drug Discovery sector. Track Cidara Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Cidara Therapeutics Valuation is Determined

Private company valuations like Cidara Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.